|
• July 24. FDA informs healthcare professionals that serious and sometimes fatal hypersensitivity reactions (HSR) caused by abacavir therapy are significantly more common in patients with a particular human leukocyte antigen (HLA) allele, HLA-B*5701. MedWatch Safety Information
• July 17. FDA updates healthcare professionals about recent changes made to the prescribing information for micro-bubble contrast agents. Drug Information
• July 17. Roxane Laboratories informs healthcare professionals of the recall of two lots of Sodium Polystyrene Sulfonate Suspension, a product used to treat hyperkalemia. MedWatch Safety Information
• July 14. Genentech informs healthcare professionals of reports of several cases of microangiopathic hemolytic anemia (MAHA) in patients with solid tumors receiving Avastin in combination with sunitinib malate. MedWatch Safety Information
Previous News Items |
